These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 33417587)
61. Technical and health governance aspects of the External Quality Assessment Scheme for the SARS-CoV-2 molecular tests: institutional experience performed in all clinical laboratories of a Regional Health Service. Di Gaudio F; Brunacci G; Contino F; Gallo A; Centineo F Clin Chem Lab Med; 2023 Jan; 61(1):173-179. PubMed ID: 36114825 [TBL] [Abstract][Full Text] [Related]
62. Fast Healthcare Interoperability Resources for Inpatient Deterioration Detection With Time-Series Vital Signs: Design and Implementation Study. Tseng TW; Su CF; Lai F JMIR Med Inform; 2022 Oct; 10(10):e42429. PubMed ID: 36227636 [TBL] [Abstract][Full Text] [Related]
63. Measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review. Krishnaratne S; Pfadenhauer LM; Coenen M; Geffert K; Jung-Sievers C; Klinger C; Kratzer S; Littlecott H; Movsisyan A; Rabe JE; Rehfuess E; Sell K; Strahwald B; Stratil JM; Voss S; Wabnitz K; Burns J Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013812. PubMed ID: 33331665 [TBL] [Abstract][Full Text] [Related]
64. Can OpenEHR, ISO 13606, and HL7 FHIR Work Together? An Agnostic Approach for the Selection and Application of Electronic Health Record Standards to the Next-Generation Health Data Spaces. Pedrera-Jiménez M; García-Barrio N; Frid S; Moner D; Boscá-Tomás D; Lozano-Rubí R; Kalra D; Beale T; Muñoz-Carrero A; Serrano-Balazote P J Med Internet Res; 2023 Dec; 25():e48702. PubMed ID: 38153779 [TBL] [Abstract][Full Text] [Related]
65. Implementation of a Sample Pooling Strategy for the Direct Detection of SARS-CoV-2 by Real-Time Polymerase Chain Reaction During the COVID-19 Pandemic. Chan CW; Kwon S; Matushek SM; Ciaglia C; Bethel C; Beavis KG Am J Clin Pathol; 2021 Jun; 156(1):15-23. PubMed ID: 33978164 [TBL] [Abstract][Full Text] [Related]
66. Assessment of SARS-CoV-2 tests costs and reimbursement tariffs readjustments during the COVID-19 pandemic. Caruana G; Brouillet R; Opota O; Greub G Swiss Med Wkly; 2022 May; 152():w30168. PubMed ID: 35748764 [TBL] [Abstract][Full Text] [Related]
67. Considerations for the selection of tests for SARS-CoV-2 molecular diagnostics. Erbak Yılmaz H; Iscan E; Oz O; Batur T; Erdoğan A; Kılıç S; Mutlu Z; Yılmaz M; Spring KJ Mol Biol Rep; 2022 Oct; 49(10):9725-9735. PubMed ID: 35441938 [TBL] [Abstract][Full Text] [Related]
68. Increasing diagnostic possibilities using the geneLEAD VIII platform for detection of SARS-CoV-2. Boers SA; Mourik BC; van Bussel MJAWM; de Brouwer CS; Wessels E; Claas ECJ J Virol Methods; 2021 Dec; 298():114291. PubMed ID: 34562515 [TBL] [Abstract][Full Text] [Related]
69. Understanding the Barriers to Pooled SARS-CoV-2 Testing in the United States. Fenichel EP; Koch RT; Gilbert A; Gonsalves G; Wyllie AL Microbiol Spectr; 2021 Sep; 9(1):e0031221. PubMed ID: 34378949 [TBL] [Abstract][Full Text] [Related]
70. Detection of SARS-CoV-2 RNA in Upper Respiratory Swap Samples by Pooling Method. Tok YT; Kuşkucu MA; Erdem H; Sarıbal D; Salman Yılmaz S; Nohut OK; Karaali R; Balkan İİ; Mete B; Tabak ÖF; Aygün G; Midilli K Balkan Med J; 2022 Jan; 39(1):48-54. PubMed ID: 34928231 [TBL] [Abstract][Full Text] [Related]
71. Surveillance testing using salivary RT-PCR for SARS-CoV-2 in managed quarantine facilities in Australia: A laboratory validation and implementation study. Jenney A; Chibo D; Batty M; Druce J; Melvin R; Stewardson A; Dennison A; Symes S; Kinsella P; Tran T; Mackenzie C; Johnson D; Thevarajan I; McGrath C; Matlock A; Prestedge J; Gooey M; Roney J; Bobbitt J; Yallop S; Catton M; Williamson DA Lancet Reg Health West Pac; 2022 Sep; 26():100533. PubMed ID: 35821908 [TBL] [Abstract][Full Text] [Related]
72. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Akova M; Unal S Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629 [TBL] [Abstract][Full Text] [Related]
73. Building an Electronic Medical Record System Exchanged in FHIR Format and Its Visual Presentation. Liu TJ; Lee HT; Wu F Healthcare (Basel); 2023 Aug; 11(17):. PubMed ID: 37685442 [TBL] [Abstract][Full Text] [Related]
74. Integrating a Patient Engagement App into an Electronic Health Record-Enabled Workflow Using Interoperability Standards. Lobach DF; Boxwala A; Kashyap N; Heaney-Huls K; Chiao AB; Rafter T; Lomotan EA; Harrison MI; Dymek C; Swiger J; Dullabh P Appl Clin Inform; 2022 Oct; 13(5):1163-1171. PubMed ID: 36516969 [TBL] [Abstract][Full Text] [Related]
75. Enabling Better Interoperability for HealthCare: Lessons in Developing a Standards Based Application Programing Interface for Electronic Medical Record Systems. Kasthurirathne SN; Mamlin B; Kumara H; Grieve G; Biondich P J Med Syst; 2015 Nov; 39(11):182. PubMed ID: 26446013 [TBL] [Abstract][Full Text] [Related]
76. Federated causal inference based on real-world observational data sources: application to a SARS-CoV-2 vaccine effectiveness assessment. Meurisse M; Estupiñán-Romero F; González-Galindo J; Martínez-Lizaga N; Royo-Sierra S; Saldner S; Dolanski-Aghamanoukjan L; Degelsegger-Marquez A; Soiland-Reyes S; Van Goethem N; Bernal-Delgado E; BMC Med Res Methodol; 2023 Oct; 23(1):248. PubMed ID: 37872541 [TBL] [Abstract][Full Text] [Related]
77. Fast Healthcare Interoperability Resources (FHIR) in a FAIR Metadata Registry for COVID-19 Research. Klopfenstein SAI; Vorisek CN; Shutsko A; Lehne M; Sass J; Löbe M; Schmidt CO; Thun S Stud Health Technol Inform; 2021 Nov; 287():73-77. PubMed ID: 34795084 [TBL] [Abstract][Full Text] [Related]
78. Optimization of the STARlet workflow for semi-automatic SARS-CoV-2 screening of swabs and deep respiratory materials using the RealAccurate Quadruplex SARS-CoV-2 PCR kit and Allplex SARS-CoV-2 PCR kit. Flipse J; Tromp AT; Thijssen D; van Xanten-Jans-Beken N; Pauwelsen R; van der Veer HJ; Schlaghecke JM; Swanink CMA Microbiol Spectr; 2024 Feb; 12(2):e0329623. PubMed ID: 38193688 [TBL] [Abstract][Full Text] [Related]
79. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial. Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T; Trials; 2021 May; 22(1):343. PubMed ID: 34001215 [TBL] [Abstract][Full Text] [Related]
80. Accessible and Adaptable Multiplexed Real-Time PCR Approaches to Identify SARS-CoV-2 Variants of Concern. Yan T; Xu Y; Zheng R; Zeng X; Chen Z; Lin S; Xia Z; Liao Y; Zhang Y; Li Q Microbiol Spectr; 2022 Oct; 10(5):e0322222. PubMed ID: 36106882 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]